Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.381%)
Open: 425.00
High: 425.00
Low: 425.00
Prev. Close: 425.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer and Director's Interests

8 Nov 2016 12:47

RNS Number : 6265O
Avingtrans PLC
08 November 2016
 

8 November 2016

Avingtrans plc

("Avingtrans" or the "Company")

Result of Tender Offer and Directors' Interests

The Company today announces the results of the Tender Offer set out in the shareholder circular published by the Company on 3 October 2016 (the "Circular"). The Tender Offer closed at 1.00 p.m. on 4 November 2016.

Result of Tender Offer

Under the Tender Offer, 9,691,361 Ordinary Shares were validly tendered and 9,691,361 Ordinary Shares will be purchased at a price per Ordinary Share of 200p, for an aggregate purchase price of £19.4 million. The Ordinary Shares to be purchased under the Tender Offer represent approximately 35 per cent. of the Company's issued ordinary share capital.

It is anticipated that the proceeds payable under the Tender Offer to the Company's shareholders who hold their Ordinary Shares in certificated form will be despatched no later than 21 November 2016 in the form of a cheque. Those shareholders who hold their Ordinary Shares in uncertificated form will have their CREST accounts credited no later than 21 November 2016.

As set out in the Circular, the Ordinary Shares will be purchased by Numis pursuant to the Tender Offer and the Company will purchase such Ordinary Shares from Numis under the terms of the Repurchase Agreement described in the Circular. The Company intends to cancel the Ordinary Shares purchased by it under the Repurchase Agreement, reducing the number of Ordinary Shares in issue from 28,009,249 Ordinary Shares to 18,317,888 Ordinary Shares.

Directors' Interests

The Directors' participation in the Tender Offer is set out below:

Number of Ordinary Shares prior to the Tender Offer

Percentage of issued share capital prior to the Tender Offer

Number of Ordinary Shares sold under the Tender Offer at 200p per Ordinary Share

Number of Ordinary Shares following the Tender Offer

Percentage of issued ordinary share capital following cancellation of the Tender Offer shares

Roger McDowell

2,406,409

8.6

1,000,000

1,406,409

7.7

Steve McQuillan

431,707

1.5

206,707

225,000

1.2

Stephen King

360,495

1.3

180,247

180,248

1.0

Jeremy Hamer

114,500

0.4

85,000

29,500

0.2

Graham Thornton

40,000

0.1

20,000

20,000

0.1

Les Thomas

-

-

-

-

-

Austen Adams

-

-

-

-

-

 

Capitalised terms used in this announcement have the same meanings given to them in the Circular.

Enquiries:

 

Avingtrans plc

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

0135 469 2391

Numis

Richard Thomas (Corporate Finance and Nominated Adviser)

Tom Ballard (Corporate Broking)

 

0207 260 1000

N+1 Singer (Joint Broker)

Shaun Dobson

Lauren Kettle

020 7496 3000

 

Newgate (Financial PR)

Adam Lloyd

Ed Treadwell

020 7653 9850

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RTEUWRURNWAARAA
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.